Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
114.49
-3.83 (-3.24%)
At close: Jul 31, 2026, 4:00 PM EDT
116.76
+2.27 (1.98%)
After-hours: Jul 31, 2026, 7:54 PM EDT
Corcept Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 111.04 | 120.5 | 127.67 | 135.55 | 66.33 | 77.62 |
Short-Term Investments | 197.16 | 251.66 | 255.67 | 232.67 | 365.34 | 145.92 |
Cash & Short-Term Investments | 308.2 | 372.15 | 383.33 | 368.22 | 431.67 | 223.54 |
Cash Growth | -9.94% | -2.92% | 4.10% | -14.70% | 93.11% | -49.28% |
Accounts Receivable | 76.92 | 59.79 | 53.98 | 41.12 | 31.06 | 27.63 |
Other Receivables | - | - | - | 14 | 14 | - |
Total Trade Receivables | 76.92 | 59.79 | 53.98 | 55.12 | 45.06 | 27.63 |
Inventory | 13.19 | 12.87 | 12.41 | 7.73 | 6.1 | 4.99 |
Other Current Assets | 41.37 | 40.66 | 21.88 | 27.56 | 16.42 | 10.32 |
Total Current Assets | 439.68 | 485.46 | 471.6 | 458.64 | 499.25 | 266.46 |
Net Property, Plant & Equipment | 11.99 | 6.47 | 8.01 | 0.32 | 1.78 | 1.52 |
Long-Term Investments | 236.45 | 160.27 | 219.83 | 57.18 | 4.95 | 112.28 |
Other Long-Term Assets | 200.58 | 184.44 | 141.11 | 105.39 | 77.45 | 43.5 |
Total Assets | 888.7 | 836.65 | 840.55 | 621.52 | 583.43 | 423.76 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 14.91 | 40.44 | 15.38 | 17.4 | 11.98 | 6.91 |
Accrued Expenses | 136.98 | 124.56 | 124.57 | 86.96 | 59.37 | 40.11 |
Current Portion of Leases | 1.92 | 1.08 | 0.83 | 0.15 | 1.14 | 0.53 |
Total Current Liabilities | 153.8 | 166.09 | 140.77 | 104.51 | 72.49 | 47.54 |
Long-Term Leases | 7.5 | 5.02 | 6.11 | - | - | - |
Other Long-Term Liabilities | 21.62 | 17.74 | 14.08 | 10.31 | 9.1 | 0.41 |
Total Long-Term Liabilities | 29.12 | 22.76 | 20.19 | 10.31 | 9.1 | 0.41 |
Total Liabilities | 182.93 | 188.85 | 160.96 | 114.81 | 81.59 | 47.95 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.14 | 0.14 | 0.14 | 0.13 | 0.13 | 0.13 |
Treasury Stock | -998.01 | -966.59 | -696.17 | -635.08 | -456.15 | -410.41 |
Additional Paid-in Capital | 1,049 | 968.6 | 832.11 | 738.52 | 662.34 | 591.35 |
Accumulated Other Comprehensive Income | 0.44 | 2.26 | -0.22 | 0.61 | -0.87 | -0.23 |
Retained Earnings | 654.61 | 643.39 | 543.74 | 402.53 | 296.39 | 194.97 |
Shareholders' Equity | 705.78 | 647.81 | 679.59 | 506.71 | 501.84 | 375.81 |
Total Liabilities & Equity | 888.7 | 836.65 | 840.55 | 621.52 | 583.43 | 423.76 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 9.42 | 6.11 | 6.94 | 0.15 | 1.14 | 0.53 |
Net Cash (Debt) | 298.78 | 366.05 | 376.4 | 368.07 | 430.53 | 223.01 |
Net Cash Growth | -10.98% | -2.75% | 2.26% | -14.51% | 93.05% | -49.10% |
Net Cash Per Share | 2.59 | 3.05 | 3.32 | 3.29 | 3.71 | 1.77 |
Book Value | 705.78 | 647.81 | 679.59 | 506.71 | 501.84 | 375.81 |
Book Value Per Share | 6.11 | 5.40 | 5.99 | 4.53 | 4.33 | 2.98 |
Tangible Book Value | 705.78 | 647.81 | 679.59 | 506.71 | 501.84 | 375.81 |
Tangible Book Value Per Share | 6.11 | 5.40 | 5.99 | 4.53 | 4.33 | 2.98 |